Biotech Startups
10,002 companies tagged Biotech, with their investors and founders.
0 investors
0 investors
The company develops expansion microscopy technology that enables nanoscale imaging of large brain tissue sections by permeating them with absorbent material and expanding with water, preserving molecular information.
0 investors
0 investors
Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them. The founders describe backgrounds building manufacturing platforms and scaling production within the cell therapy industry.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
0 investors
0 investors
Far UV Technologies designs and manufactures germicidal UV light systems and environmental infection control products for reducing or eliminating pathogens in indoor spaces across healthcare, education, commercial, and transportation sectors. The company operates through its own technology and through AeroMed, Inc., a subsidiary with over 30 years of experience in infection control engineering.
0 investors
Biotechnology company developing CAR-T therapeutics using a novel M83 co-stimulatory domain platform for enhanced efficacy against solid tumors.
0 investors
0 investors
0 investors
0 investors
0 investors
Femasys develops office-based medical devices for women's healthcare, including first-line fertility treatments (FemaSeed, FemHSG catheter) delivered by OB/GYNs and fertility specialists, and a minimally invasive permanent birth control system (FemBloc). Its products aim to provide more affordable, less invasive alternatives to IVF and surgical contraception.
0 investors
Fermeate develops a hardware module that connects to existing bioreactors and uses precisely timed light pulses to trigger genetic switches in production microorganisms, controlling yield, strain stability, and feedstock flexibility. It serves industrial fermentation operators across product categories such as amino acids, proteins, food and specialty ingredients, specialty chemicals, and flavors and fragrances.
0 investors
FGH BioTech develops small molecule drugs that regulate SREBP transcription factors and related pathways, targeting the prevention and treatment of metabolic diseases and cancer. The company's work is based on decades of research in fat and energy metabolism.
0 investors
0 investors